Patient Understanding of LiverMultiScan
1 other identifier
observational
101
1 country
1
Brief Summary
This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 17, 2016
CompletedFirst Posted
Study publicly available on registry
August 24, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJanuary 12, 2018
January 1, 2018
1.8 years
August 17, 2016
January 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Factors effecting MRI experience and understanding.
This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.
Immediately (within 1 hour) after undergoing the MRI scan, and receiving results feedback.
Secondary Outcomes (1)
Comparison of MRI to ultrasound scan in terms of patient experience.
Immediately (within 1 hour) after undergoing an MRI scan, and ultrasound (FibroScan) scan.
Study Arms (1)
Experience of liver disease
This is defined as either those who have had direct experience of liver disease as sufferers, or the carers of those who have had liver disease. Each individual receives an MRI (LiverMultiScan), with many also receiving a FibroScan.
Interventions
Eligibility Criteria
Individuals with experience of liver disease, either as a sufferer or carer.
You may qualify if:
- Individuals with experience of liver disease.
- Individuals over the age of 16.
- Individuals willing to give informed consent for participation in the study.
You may not qualify if:
- Individuals with any contraindication to magnetic resonance imaging.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Perspectumlead
Study Sites (1)
University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Oxford, Oxfordshire, OX3 9DU, United Kingdom
Related Publications (1)
McKay A, Pantoja C, Hall R, Matthews S, Spalding P, Banerjee R. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. J Patient Rep Outcomes. 2021 Sep 10;5(1):89. doi: 10.1186/s41687-021-00363-5.
PMID: 34508298DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rajarshi Banerjee, BM BCh MRCP MSc DPhil
Perspectum Diagnostics
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2016
First Posted
August 24, 2016
Study Start
February 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
January 12, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share